TABLE 2.
R-pyocin production and susceptibility of 47 clinical isolates
| Isolate | R-pyocin type | SNP genotype | Serotypea | Lysis byb: |
||
|---|---|---|---|---|---|---|
| R1-pyocin | R2-pyocin | R5-pyocin | ||||
| 03101 | A42A | O1 | + | + | + | |
| 05101 | 6C22 | O1 | + | + | + | |
| 13104 | 0C1A | O1 | + | + | + | |
| 13112 | C40A | O1 | + | + | + | |
| 15109 | F429 | O1 | + | + | + | |
| 27101 | EC4A | O1 | + | + | + | |
| 13120 | 6592 | O3 | + | + | + | |
| 15104 | F62A | O3 | + | + | + | |
| 24101 | 2C25 | O3 | + | + | + | |
| 06101 | 279A | O6 | + | + | + | |
| 06103 | CC2A | O6 | + | + | + | |
| 13113 | 0F9E | O6 | + | − | + | |
| 27102 | 841E | NT | + | + | − | |
| 13109 | 1 | F429 | O1 | − | + | + |
| 01101 | 1 | 1BAE | O6 | − | + | + |
| 06104 | 1 | AF9A | O6 | − | − | + |
| 10107 | 1 | 2C2A | O6 | − | + | + |
| 13106 | 1 | 4F8A | O6 | − | + | + |
| 13108 | 1 | 1BAE | O6 | − | + | + |
| 13111 | 1 | 85AA | O6 | − | + | − |
| 13128 | 1 | 062A | O6 | − | ± | − |
| 15101 | 1 | 0C2E | O6 | − | + | + |
| 16101 | 1 | 0C2E | O6 | − | + | + |
| 19105 | 1 | 7C2E | O6 | − | + | + |
| 26103 | 1 | 4F92 | O6 | − | + | − |
| PAK | 1 | 55AA | O6 | − | + | + |
| PAO1 | 2 | 0002 | O5 | − | − | − |
| 27103 | 2 | 0812 | O5 | − | − | − |
| PA14 | 2 | D421 | O10 | − | − | − |
| 06105 | 2 | D421 | O10 | − | − | − |
| 10103 | 2 | D421 | O10 | − | − | − |
| 13124 | 2 | D421 | O10 | − | − | ± |
| 30101 | 2 | D421 | O10 | − | − | − |
| 13122 | 2 | F661 | O10 | − | − | ± |
| 13119 | 2 | 239A | O12 | − | − | − |
| 13118-S1 | 2 | 239A | O15 | − | − | + |
| 08102 | 5 | 2C1A | O4 | + | + | − |
| 10102 | 5 | 2F92 | O4 | + | + | − |
| 21106 | 5 | 4F82 | O4 | − | − | − |
| 03103 | 5 | 0F92 | O11 | ± | − | − |
| 15102 | 5 | E429 | O11 | − | − | − |
| 19101 | 5 | F469 | O11 | − | − | − |
| 08101 | 5 | F469 | O11 | − | − | − |
| 13117 | 5 | F469 | O11 | − | − | − |
| 22101 | 5 | F469 | O11 | − | − | − |
| 26101 | 5 | F469 | O11 | − | − | − |
| 19102 | 5 | 6D92 | O12 | − | − | − |
| 21102 | 5 | 6D92 | O12 | − | − | − |
| 15108 | 5 | E429 | O15 | + | ± | − |
| 28101 | 5 | 261A | NT | − | − | − |
a
LPS O-serotype lysis was determined with supernatants from strains PAK (R1-pyocin), PA14 (R2-pyocin), and 15108-1 (R5-pyocin), and the results were compared to those for the corresponding R-pyocin deletion mutant. NT, not typeable.
b
+, lysis; −, no lysis; ±, weak or fuzzy lysis zone.